In the PM group, a high risk of side effects due to tramadol, such as serotonin syndrome, can be expected; and in the UM group, a high risk of μ-opioid receptor-related side effects, such as respiratory depression, can be expected relative to other CYP2D6 genotypes [16]. This evidence concerns the gene CYP2D6 and Respiratory insufficiency due to muscle weakness.